J.M. Brogard

910 total citations
63 papers, 672 citations indexed

About

J.M. Brogard is a scholar working on Pharmacology, Oncology and Molecular Medicine. According to data from OpenAlex, J.M. Brogard has authored 63 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pharmacology, 27 papers in Oncology and 15 papers in Molecular Medicine. Recurrent topics in J.M. Brogard's work include Antibiotics Pharmacokinetics and Efficacy (34 papers), Drug Transport and Resistance Mechanisms (25 papers) and Antibiotic Resistance in Bacteria (15 papers). J.M. Brogard is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (34 papers), Drug Transport and Resistance Mechanisms (25 papers) and Antibiotic Resistance in Bacteria (15 papers). J.M. Brogard collaborates with scholars based in France. J.M. Brogard's co-authors include Jean-Frédéric Westphal, D Vetter, H. Monteil, F. Jehl, Jean‐Frédéric Blickle, M. Pinget, M Adloff, J.P. Arnaud, J F Blicklé and R Minck and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

J.M. Brogard

61 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M. Brogard France 14 308 139 119 119 106 63 672
J. P. Fillastre France 15 248 0.8× 108 0.8× 115 1.0× 89 0.7× 67 0.6× 56 761
Allan H. Price United Kingdom 7 360 1.2× 77 0.6× 102 0.9× 160 1.3× 175 1.7× 9 1.0k
Stuart A. Kleit United States 15 392 1.3× 189 1.4× 90 0.8× 85 0.7× 73 0.7× 31 814
Andrew D. Blair United States 16 270 0.9× 90 0.6× 126 1.1× 163 1.4× 55 0.5× 31 901
J P Fillastre France 18 477 1.5× 127 0.9× 100 0.8× 218 1.8× 199 1.9× 75 1.0k
Donald P. Reitberg United States 13 233 0.8× 162 1.2× 110 0.9× 164 1.4× 62 0.6× 26 1.1k
Mark A. Gill United States 17 422 1.4× 70 0.5× 105 0.9× 199 1.7× 157 1.5× 60 987
Jean-Frédéric Westphal France 13 184 0.6× 146 1.1× 68 0.6× 167 1.4× 72 0.7× 23 637
J J Schentag United States 16 541 1.8× 120 0.9× 87 0.7× 223 1.9× 205 1.9× 32 1.0k
Susan Willavize United States 14 232 0.8× 55 0.4× 109 0.9× 183 1.5× 116 1.1× 31 653

Countries citing papers authored by J.M. Brogard

Since Specialization
Citations

This map shows the geographic impact of J.M. Brogard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Brogard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Brogard more than expected).

Fields of papers citing papers by J.M. Brogard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Brogard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Brogard. The network helps show where J.M. Brogard may publish in the future.

Co-authorship network of co-authors of J.M. Brogard

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Brogard. A scholar is included among the top collaborators of J.M. Brogard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Brogard. J.M. Brogard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andrès, Emmanuel, Anne-Élisabeth Perrin, A. Ruellan, et al.. (2003). Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities.. PubMed. 50(49). 192–5. 34 indexed citations
2.
Blicklé, J F, et al.. (1999). Actualités dans les traitements du diabète de type 2. Les agents insulinosécréteurs. La Revue de Médecine Interne. 20. 351s–359s. 1 indexed citations
3.
Blicklé, J F, Emmanuel Andrès, & J.M. Brogard. (1999). Actualités dans les traitements du diabète de type 2. Les inhibiteurs des alpha-glucosidases. La Revue de Médecine Interne. 20. 379s–383s. 10 indexed citations
4.
Stahl, A, et al.. (1998). Short-term variations of serum glycated apolipoprotein B.. PubMed. 24(2). 151–5. 4 indexed citations
5.
Westphal, Jean-Frédéric, D Vetter, & J.M. Brogard. (1994). Hepatic side-effects of antibiotics. Journal of Antimicrobial Chemotherapy. 33(3). 387–401. 139 indexed citations
6.
Brogard, J.M., et al.. (1994). Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluation.. PubMed. 20(6). 247–55. 5 indexed citations
7.
Brogard, J.M., et al.. (1992). Le rôle des polyols dans le développement des complications du diabète. Intérêt des inhibiteurs de l'aldose-réductase. La Revue de Médecine Interne. 13(1). 69–79. 2 indexed citations
8.
Westphal, Jean-Frédéric, Antoine Deslandes, J.M. Brogard, & C Carbon. (1991). Reappraisal of amoxycillin absorption kinetics. Journal of Antimicrobial Chemotherapy. 27(5). 647–654. 22 indexed citations
9.
Westphal, Jean-Frédéric, et al.. (1991). Management of biliary tract infections: potential role of the qninoiones. Journal of Antimicrobial Chemotherapy. 28(4). 486–490. 17 indexed citations
10.
Brogard, J.M., et al.. (1989). Clinical Pharmacokinetics of Cefotiam. Clinical Pharmacokinetics. 17(3). 163–174. 15 indexed citations
11.
Brogard, J.M., et al.. (1989). Inhibiteurs des alpha-glucosidases: une nouvelle approche thérapeutique du diabète et des hypoglycémies fonctionnelles. La Revue de Médecine Interne. 10(4). 365–374. 13 indexed citations
12.
Brogard, J.M., F. Jehl, M Adloff, Jean‐Frédéric Blickle, & H. Monteil. (1988). High hepatic excretion in humans of cefpiramide, a new cephalosporin. Antimicrobial Agents and Chemotherapy. 32(9). 1360–1364. 9 indexed citations
13.
Brogard, J.M., et al.. (1988). [The role of ciprofloxacine metabolites in its biliary and urinary elimination in man].. PubMed. 36(5 Pt 2). 719–23. 3 indexed citations
14.
Jehl, F., M Adloff, H. Monteil, & J.M. Brogard. (1987). Ciprofloxacin biliary disposition in cholecystectomised patients with special references to HPLC and bioassay data. European Journal of Drug Metabolism and Pharmacokinetics. 12(2). 115–122. 5 indexed citations
15.
Brogard, J.M., et al.. (1986). Biliary Elimination of Cefotiam, an Experimental and Clinical Study. Chemotherapy. 32(3). 222–235. 5 indexed citations
16.
Brogard, J.M., et al.. (1980). Le passage biliaire de la céfuroxime : étude expérimentale, évaluation clinique. Médecine et Maladies Infectieuses. 10(9). 445–452. 1 indexed citations
17.
Brogard, J.M., et al.. (1980). Biliary elimination of mezlocillin: an experimental and clinical study. Antimicrobial Agents and Chemotherapy. 18(1). 69–76. 23 indexed citations
18.
Pinget, M., et al.. (1979). Dépistage des états diabétiques au cours de la grossesse.. 130(12).
19.
Brogard, J.M., et al.. (1976). Experimental and clinical pharmacology of metampicillin in the biliary tract. Journal of Antimicrobial Chemotherapy. 2(4). 363–371. 4 indexed citations
20.
Pinget, M., et al.. (1976). Biliary excretion of ampicillin, metampicillin and carbenicillin. Journal of Antimicrobial Chemotherapy. 2(2). 195–201. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. P. Fillastre Breakdown of academic impact, for papers by Allan H. Price Breakdown of academic impact, for papers by Stuart A. Kleit Breakdown of academic impact, for papers by Andrew D. Blair Breakdown of academic impact, for papers by J P Fillastre Breakdown of academic impact, for papers by Donald P. Reitberg Breakdown of academic impact, for papers by Mark A. Gill Breakdown of academic impact, for papers by Jean-Frédéric Westphal Breakdown of academic impact, for papers by J J Schentag Breakdown of academic impact, for papers by Susan Willavize
Rankless by CCL
2026